‌

US Patent 10660968 Spirocyclic degronimers for target protein degradation

Patent 10660968 was granted and assigned to C4 Therapeutics on May, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

C4 Therapeutics

Current Assignee

C4 Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

106609680

Date of Patent

May 26, 2020

Patent Application Number

161863340

Date Filed

November 9, 2018

Patent Citations Received

‌

US Patent 12091397 Dihydroquinolinones for medical treatment

‌

US Patent 11524949 Degraders and Degrons for targeted protein degradation

‌

US Patent 11459335 N/O-linked Degrons and Degronimers for protein degradation

‌

US Patent 11560381 Compounds and uses thereof

‌

US Patent 10905768 Heterocyclic degronimers for target protein degradation

‌

US Patent 11584748 Spirocyclic compounds

...

Patent Primary Examiner

‌

Rei Tsang Shiao

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10660968 Spirocyclic degronimers for target protein degradation

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API